STAAR Surgical Co STAA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:13 PM EST
103.83quote price arrow down-2.68 (-2.52%)
Volume
182,806
52 week range
23.20 - 128.23

...

Loading . . .

KEY STATS

  • Open106.91
  • Day High107.18
  • Day Low101.85
  • Prev Close106.51
  • 52 Week High128.23
  • 52 Week High Date02/19/21
  • 52 Week Low23.20
  • 52 Week Low Date03/16/20
  • Market Cap4.834B
  • Shares Out46.56M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • 1 Year % Change226.3

RATIOS/PROFITABILITY

  • EPS (TTM)0.12
  • P/E (TTM)866.69
  • Fwd P/E (NTM)988.86
  • EBITDA (MRQ)11.273M
  • ROE (MRQ)3.31%
  • Revenue (MRQ)163.46M
  • Gross Margin (MRQ)72.41%
  • Net Margin (MRQ)3.62%
  • Debt To Equity (MRQ)0.90%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest STAAR Surgical Co News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29...
Louis Silverman
Chairman
Caren Mason
President
Patrick Williams
Chief Financial Officer
Keith Holliday Ph.D.
Chief Technology Officer
Jon Hayashida
Vice President
Address
25651 Atlantic Ocean Drive
Lake Forest, CA
92630
United States